ALBT has undergone a complete business transformation from a diagnostic/laboratory services company to an AI-focused technology company while experiencing severe cash depletion and massive losses.
The company has fundamentally pivoted its entire business model, abandoning its previous focus on breathalyzer devices and laboratory services to pursue AI acquisitions and technology markets. This represents a complete strategic overhaul that introduces significant execution risk and uncertainty about management's ability to successfully operate in an entirely different industry vertical.
ALBT's financial condition has deteriorated dramatically, with cash plummeting 96% to just $109K while net losses more than doubled to $18.3M and interest expenses surged 422%. Despite the severe cash burn and widening losses, stockholders' equity paradoxically increased 30%, likely due to equity raises that have since been spent down. The company appears to be in a critical cash position while pursuing an expensive business transformation, creating substantial near-term liquidity risk.
Capital expenditure jumped 1167% — major investment cycle underway; assess returns on deployment.
Interest expense surged 422% — significant debt increase or rising rates materially impacting earnings.
Inventory surged 387.2% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.
Net income declined 131.1% — review whether driven by operations, interest costs, or non-recurring items.
Cash declined 96.2% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
R&D spending cut 85% — could signal cost discipline or concerning reduction in innovation investment.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Current assets declined 53.8% — monitor working capital adequacy and short-term liquidity.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Equity base grew 30% — retained earnings accumulation or equity issuance strengthening the balance sheet.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →